DC Investments Management’s GSK GSK Stock Holding History

DC Investments Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,122	Closed	-$261K	–	164
2020 Q2	$261K	Sell	5,122 -4,842	-49%	-$248K	0.1%	259
2020 Q1	$472K	Sell	9,964 -4,586	-32%	-$245K	0.38%	78
2019 Q4	$855K	Buy	14,550 +460	+3%	+$25.6K	0.65%	21
2019 Q3	$752K	Sell	14,090 -4,108	-23%	-$211K	0.44%	25
2019 Q2	$910K	Sell	18,198 -3,303	-15%	-$166K	0.51%	15
2019 Q1	$1.12M	Hold	21,501	–	–	0.71%	11
2018 Q4	$1.03M	Buy	21,501 +5,176	+32%	+$255K	0.84%	4
2018 Q3	$820K	Buy	16,325 +35	+0.2%	+$1.78K	0.55%	20
2018 Q2	$821K	Buy	+16,290	New	+$820K	0.52%	15

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

DC Investments Management's GSK Position: Q3 2020 in Review

DC Investments Management sold out of GSK (GSK) in Q3 2020, closing a stake of 5,122 shares — an estimated $261K sold.

DC Investments Management first reported a position in GSK in Q2 2018 and held it in 9 quarters. The position peaked at $1.12M in Q1 2019. 827 funds tracked by Wall St. Rank hold GSK as of Q3 2020.

DC Investments Management reported no remaining GSK position as of Q3 2020 after selling out during the quarter.
DC Investments Management sold 5,122 GSK shares in Q3 2020, an estimated $261K.
DC Investments Management first reported a position in GSK in Q2 2018 and held it in 9 quarters.
DC Investments Management's GSK position peaked at $1.12M in Q1 2019.
827 funds tracked by Wall St. Rank held GSK as of Q3 2020.

Based on DC Investments Management's 13F filing for Q3 2020, filed 4 Nov 2020.